Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements - Assets And Liabilities Measured At Fair Value (Details)

v2.4.0.8
Fair Value Measurements - Assets And Liabilities Measured At Fair Value (Details) (Fair Value, Measurements, Recurring [Member], USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Level 1 [Member]
   
Assets:    
Total assets $ 174,492 $ 26,952
Liabilities:    
Total liabilities 0 0
Level 2 [Member]
   
Assets:    
Total assets 13,015 2,692
Liabilities:    
Total liabilities 0 10
Level 3 [Member]
   
Assets:    
Total assets    2,040
Liabilities:    
Total liabilities 178,160 30,159
Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets 187,507 31,684
Liabilities:    
Total liabilities 178,160 30,169
Forward contracts [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0 0
Forward contracts [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 49 10
Forward contracts [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 0 0
Forward contracts [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 49 10
Embedded conversion option [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0  
Embedded conversion option [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 0  
Embedded conversion option [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 101,087  
Embedded conversion option [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 101,087  
Deferred acquisition payments, net of discount [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0 0
Deferred acquisition payments, net of discount [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 0 0
Deferred acquisition payments, net of discount [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 5,465 10,103
Deferred acquisition payments, net of discount [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 5,465 10,103
Contingent consideration [Member] | CURNA [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | CURNA [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | CURNA [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 573 510
Contingent consideration [Member] | CURNA [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 573 510
Contingent consideration [Member] | Opko Diagnostics [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | Opko Diagnostics [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | Opko Diagnostics [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 13,776 12,974
Contingent consideration [Member] | Opko Diagnostics [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 13,776 12,974
Contingent consideration [Member] | FineTech [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | FineTech [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | FineTech [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 3,124 5,262
Contingent consideration [Member] | FineTech [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 3,124 5,262
Contingent consideration [Member] | Cytochroma [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0  
Contingent consideration [Member] | Cytochroma [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 0  
Contingent consideration [Member] | Cytochroma [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 53,092  
Contingent consideration [Member] | Cytochroma [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 53,092  
Contingent consideration [Member] | Farmadiet [Member] | Level 1 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | Farmadiet [Member] | Level 2 [Member]
   
Liabilities:    
Total liabilities 0 0
Contingent consideration [Member] | Farmadiet [Member] | Level 3 [Member]
   
Liabilities:    
Total liabilities 1,043 1,310
Contingent consideration [Member] | Farmadiet [Member] | Estimate of Fair Value Measurement [Member]
   
Liabilities:    
Total liabilities 1,043 1,310
Money market funds [Member] | Level 1 [Member]
   
Assets:    
Total assets 168,418 18,716
Money market funds [Member] | Level 2 [Member]
   
Assets:    
Total assets 0 0
Money market funds [Member] | Level 3 [Member]
   
Assets:    
Total assets 0 0
Money market funds [Member] | Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets 168,418 18,716
Certificates of Deposit [Member] | Level 1 [Member]
   
Assets:    
Total assets 0 0
Certificates of Deposit [Member] | Level 2 [Member]
   
Assets:    
Total assets 827 820
Certificates of Deposit [Member] | Level 3 [Member]
   
Assets:    
Total assets 0 0
Certificates of Deposit [Member] | Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets 827 820
Notes Receivable [Member]
   
Assets:    
Total assets 0  
Notes Receivable [Member] | Level 1 [Member]
   
Assets:    
Total assets 0  
Notes Receivable [Member] | Level 2 [Member]
   
Assets:    
Total assets 6,151  
Notes Receivable [Member] | Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets 6,151  
Common Stock [Member] | Level 1 [Member]
   
Assets:    
Total assets 6,074 8,236
Common Stock [Member] | Level 2 [Member]
   
Assets:    
Total assets 0 0
Common Stock [Member] | Level 3 [Member]
   
Assets:    
Total assets 0 0
Common Stock [Member] | Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets 6,074 8,236
BZNE Note and conversion feature [Member] | Level 1 [Member]
   
Assets:    
Total assets 0 0
BZNE Note and conversion feature [Member] | Level 2 [Member]
   
Assets:    
Total assets 5,988 0
BZNE Note and conversion feature [Member] | Level 3 [Member]
   
Assets:    
Total assets    2,040
BZNE Note and conversion feature [Member] | Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets 5,988 2,040
Neovasc common stock options [Member] | Level 1 [Member]
   
Assets:    
Total assets   0
Neovasc common stock options [Member] | Level 2 [Member]
   
Assets:    
Total assets   1,394
Neovasc common stock options [Member] | Level 3 [Member]
   
Assets:    
Total assets   0
Neovasc common stock options [Member] | Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets   1,394
Neovasc common stock warrants [Member] | Level 1 [Member]
   
Assets:    
Total assets   0
Neovasc common stock warrants [Member] | Level 2 [Member]
   
Assets:    
Total assets   478
Neovasc common stock warrants [Member] | Level 3 [Member]
   
Assets:    
Total assets   0
Neovasc common stock warrants [Member] | Estimate of Fair Value Measurement [Member]
   
Assets:    
Total assets   $ 478